Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice
- 27 August 2004
- Vol. 23 (7) , 924-931
- https://doi.org/10.1016/j.vaccine.2004.07.031
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Induction of CD8 T-Cell-Specific Systemic and Mucosal Immunity against Herpes Simplex Virus with CpG-Peptide ComplexesJournal of Virology, 2002
- Intranasal Immunization with Killed Unencapsulated Whole Cells Prevents Colonization and Invasive Disease by Capsulated PneumococciInfection and Immunity, 2001
- Safety and Immunogenicity of a Proteosome- Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy AdultsInfection and Immunity, 2001
- Immunization Against Hepatitis B Virus by Mucosal Administration of Antigen–Antibody ComplexesViral Immunology, 1998
- Proteosomes, Emulsomes, and Cholera Toxin B Improve Nasal Immunogenicity of Human Immunodeficiency Virus gp160 in Mice: Induction of Serum, Intestinal, Vaginal, and Lung IgA and IgGThe Journal of Infectious Diseases, 1997
- Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodiesVirus Research, 1996
- Optimization of Poly(ethylene glycol) Precipitation of Hepatitis A Virus Used To Prepare VAQTA, a Highly Purified Inactivated VaccineBiotechnology Progress, 1996